CAMP4 THERAPEUTICS CORPORATION
CAMP
$3.45+0.58%
End of day · as of Oct 15, 2026, 5:45 PM ET
Mkt cap
$214.97M
EV/Sales
30.1
P/E ratio
N/A
FY2025 Revenue
$3.50M
EPS (TTM)
$-2.31
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-2298.54%
Beta
N/A
Div yield
N/A
Sector
Healthcare
CAMP4 THERAPEUTICS CORPORATION (CAMP) is a biotechnology company listed on NASDAQ.
Latest reported CAMP revenue for 2025-12-31 was $3.5M. Net income was -$80.4M. Revenue was up 436.5% from 2024-12-31 to 2025-12-31. CAMP currently screens at market cap $215.0M.
Use this CAMP research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CAMP income, balance, and cash tables.
CAMP4 THERAPEUTICS CORPORATION (CAMP) is a biotechnology company in the Healthcare sector.
Latest cached CAMP4 THERAPEUTICS CORPORATION (CAMP) revenue for Dec 31, 2025 was $3.5M. Net income was -$80.4M. Statements: https://lician.com/financials/camp
CAMP4 THERAPEUTICS CORPORATION (CAMP) market capitalization is $215.0M on the latest cached snapshot.
CAMP4 THERAPEUTICS CORPORATION (CAMP) cached previous close $3.43; day range $3.43 – $3.52; volume 50,579. Session quote: https://lician.com/quote/camp
CAMP4 THERAPEUTICS CORPORATION (CAMP) latest cached earnings event is "CAMP earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CAMP filing is 8-K · Sep 28, 2026. Filings: https://lician.com/sec/camp